NDC 64950-424

Yosprala

Aspirin And Omeprazole

Yosprala is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Genus Lifesciences Inc.. The primary component is Aspirin; Omeprazole.

Product ID64950-424_25e5b5c2-b34c-4b12-89a5-baaba3c3e344
NDC64950-424
Product TypeHuman Prescription Drug
Proprietary NameYosprala
Generic NameAspirin And Omeprazole
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-03-04
Marketing CategoryNDA / NDA
Application NumberNDA205103
Labeler NameGenus Lifesciences Inc.
Substance NameASPIRIN; OMEPRAZOLE
Active Ingredient Strength81 mg/1; mg/1
Pharm ClassesProton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 64950-424-30

30 TABLET, FILM COATED in 1 BOTTLE (64950-424-30)
Marketing Start Date2019-03-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64950-424-90 [64950042490]

Yosprala TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205103
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-04

NDC 64950-424-30 [64950042430]

Yosprala TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205103
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-04

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN81 mg/1

OpenFDA Data

SPL SET ID:6a386a07-852f-4b24-878a-1e53317e1717
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1811632
  • 1811631
  • 1811916
  • 1811918
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]
    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "Yosprala" or generic name "Aspirin And Omeprazole"

    NDCBrand NameGeneric Name
    64950-424Yospralaaspirin and omeprazole
    64950-425Yospralaaspirin and omeprazole
    68071-5102YospralaYosprala
    70347-081YOSPRALAAspirin and Omeprazole
    70347-325YOSPRALAAspirin and Omeprazole
    71800-012Yospralaaspirin and omeprazole
    71800-016Yospralaaspirin and omeprazole
    73568-004Yospralaaspirin and omeprazole
    73568-005Yospralaaspirin and omeprazole
    71800-014aspirin and omeprazole delayed-release tabaspirin and omeprazole
    71800-018aspirin and omeprazole delayed-release tabaspirin and omeprazole
    73457-415aspirin and omeprazole delayed-release tabaspirin and omeprazole
    69597-348ASPIRIN/OMEPRAZOLEaspirin and omeprazole

    Trademark Results [Yosprala]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    YOSPRALA
    YOSPRALA
    87107388 not registered Dead/Abandoned
    POZEN Inc
    2016-07-18
    YOSPRALA
    YOSPRALA
    86011803 5124592 Live/Registered
    POZEN Inc.
    2013-07-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.